LIGHTMED TruScan Pro – Operator’s Manual Rev. No. 01 Page 95 of 109
Section 6 Clinical Use
The TruScan Pro laser system is an ophthalmic laser that coagulates or burns structures within
the patient’s eyes. During the surgical treatment, the laser energy is delivered directly onto the
patient’s eye tissue, which subsequently modifies the eye structure as intended by the doctor.
This laser system is used for performing the following clinical procedures:
• Involves the destruction of neovascular complexes
for destroying areas of microinfarction or capillary
closure.
• Uses the slit lamp LDU.
Pan retinal photocoagulation
• Involves the destruction of neovascular complexes
for destroying areas of microinfarction or capillary
closure.
• Uses either the slit lamp LDU or LIO.
• Involves the destruction of neovascular complexes
for destroying areas of microinfarction or capillary
closure.
• Uses the Endoprobe.
• Should be practiced in a sterile environment.
• Involves the destruction of leaking vessels in the
macular and paramacular regions in order to produce
a chorioretinal adhesion that can resist ongoing
vitreoretinal traction.
• Uses the slit lamp LDU.
• Photocoagulation of the trabecular meshwork to
create apertures, which then increases the flow of the
aqueous humor in order to treat open-angle
glaucoma.
• Uses the slit lamp LDU.
6.1 LDUs in Clinical Use
There are three different LDUs used with the TruScan Pro laser system. They include the slit
lamp, LIO, and Endoprobe. More details below:
Contraindications for Use
• Proliferative and non-proliferative
diabetic retinopathy.
• Retinal tears and detachments.
• Lattice degeneration.
• Laser trabeculoplasty in glaucoma
treatment.
• Opaque cornea or lens, corneal
edema, or blood in the vitreous
humor that interfered with the
treatment by scattering the beam.
• Albino patients or eyes that have no
pigmentation.
Additional Contraindications for
Trabeculoplasty Use:
To Next Page
Loading...
